From the beginning, the COVID-19 pandemic has been plagued by myths and misunderstandings about how the disease spreads and how people can protect themselves from the disease. We've come a long way in understanding COVID-19, but distrust of the vaccine prevails to the great detriment of public health.
Respiratory syncytial virus, or RSV, is a common, highly contagious virus that infects the lungs and breathing passages. In healthy adults and older children, RSV typically causes mild, cold-like symptoms.
New research reveals that intense COVID-19 viral exposure may diminish the shielding effects of vaccination and previous infection, resulting in “leaky” protection.
As climatic conditions and population growth causes frequent infectious disease outbreaks, a new study shows limited availability of software tools that can accurately forecast risks.
On May 3, the FDA approved a vaccine to prevent respiratory syncytial virus in older adults. Dr. Cindy Prins answers some common questions about RSV disease and the new vaccine.
Researchers who study outbreak transmission dynamics can offer insight to the spread and containment of COVID-19 based on past emerging coronaviruses. UF biology professor Derek Cummings has investigated outbreak dynamics of Severe Acute Respiratory Syndrome (SARS), which emerged in 2002, and Middle East Respiratory Syndrome (MERS) which emerged in 2012.
New research led by EPI-IFAS researcher KC Jeong describes for the first time precisely how the Legionnaire's disease bacterium evades detection by the immune system.
The nation's crippled vaccination program has led to record numbers in cases of measles, diphtheria and other vaccine-preventable diseases, creating a regional public health crisis.
Recently, University of Florida Health researchers discovered why an influenza virus was making young people admitted to UF Health Shands Hospital so sick: It contained a mutation that allowed it to infect the patients’ lower respiratory tracts.
